Milliporesigma Brochures

41. BioReliance® Gene Therapy Services 3/17/2020

    We are your partner for manufacturing and testing of viral gene therapies and gene-modified cell therapies. We offer manufacturing and biosafety testing for every stage of gene therapy development.

42. Benzonase® endonuclease Safety Plus Emprove® Expert Data Sheet 1/15/2020

    Benzonase® endonuclease — the smart solution for DNA removal in biopharmaceutical production.

43. Benzonase® endonuclease Safety Plus Emprove® Expert Brochure 1/15/2020

    With its new features, Benzonase ® endonuclease Safety Plus Emprove® Expert is ideally suited for manufacturing of cell and gene therapy agents such as adeno associated and lenti viruses, oncolytic viruses, and viral vector vaccines.

44. Integrated Vector Production Capabilities 10/29/2019

    From products and services to complete manufacturing offerings, find out how MilliporeSigma can help you produce better, faster viral vectors.   

45. Product Characterization Assay Package - Interlot And Biosimilar Comparability 7/14/2019

    Monoclonal antibodies (mAbs) are highly complex biomolecules easily affected by changes in the biopharmaceutical manufacturing process. Something as simple as a temperature fluctuation can produce a change in higher order structure (HOS) that renders the mAb less active or inactive. Whether your mAb is an original product or a biosimilar, our comparability studies are designed to ensure robust and reproducible mAb production.

46. Product Characterization Assay Package - Cell Line Development 7/14/2019

    Our Product Characterization services offering combines mAb physicochemical and structural information with the activity profile captured from binding, affinity, and potency bioassays to better understand the function of your drug—its critical quality attributes. All testing is performed in a GMP qualified laboratory and is compliant with ICH guidelines, FDA, and EMA regulations.

47. Product Characterization Assay Package - Impurities 7/14/2019

    Many different impurities are present in or generated during the mAb manufacturing process. We work to make sure your biotherapy’s development program isn’t derailed by process or product contaminates that can arise from raw input materials, occur as residual processing agents, or formed as reaction by-products.

48. Product Characterization Assay Package - Lot Release And Stability Testing 7/14/2019

    Before your mAb therapy reaches a patient, it is important to ensure product safety and efficacy. This includes understanding the effects of environmental conditions—temperature, humidity, light, container interactions—on your mAb. We offer a full portfolio of lot release and stability testing services performed to GMP guidelines.

49. EX-CELL® Advanced CHO Fed-Batch Medium

    EX-CELL® Advanced CHO Fed-Batch Medium is chemically defined, animal component free, and contains no hydrolysates or components of unknown composition. The formulations were developed using mulitvariate analysis of 10,000+ data points that included performance, physical, regulatory, and safety design specifications.

50. Custom Research-Grade mRNA Manufacturing Services

    Explore two research-grade packages designed to support your mRNA needs at every stage of development.